The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Lipoprotein(a) and Cardiovascular Disease
Abstract
Background: High lipoprotein(a) concentrations present in 10%–20% of the population have long been linked to increased risk of ischemic cardiovascular disease. It is unclear whether high concentrations represent an unmet medical need. Lipoprotein(a) is currently not a target for treatment to prevent cardiovascular disease. Content: The present review summarizes evidence of causality for high lipoprotein(a) concentrations gained from large genetic epidemiologic studies and discusses measurements of lipoprotein(a) and future treatment options for high values found in an estimated >1 billion individuals worldwide. Summary: Evidence from mechanistic, observational, and genetic studies support a causal role of lipoprotein(a) in the development of cardiovascular disease, including coronary heart disease and peripheral arterial disease, as well as aortic valve stenosis, and likely also ischemic stroke. Effect sizes are most pronounced for myocardial infarction, peripheral arterial disease, and aortic valve stenosis where high lipoprotein(a) concentrations predict 2- to 3-fold increases in risk. Lipoprotein(a) measurements should be performed using well-validated assays with traceability to a recognized calibrator to ensure common cut-offs for high concentrations and risk assessment. Randomized cardiovascular outcome trials are needed to provide final evidence of causality and to assess the potential clinical benefit of novel, potent lipoprotein(a) lowering therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000366 · Cited by 2,466
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
Cardiogenics, Schunkert, H., the CARDIoGRAM Consortium, König, I. R., Kathiresan, S., Reilly, M. P., Assimes, T. L., Holm, H., Preuss, M., Stewart, A. F. R., et al. (2011) · Nature Genetics · doi:10.1038/ng.784 · Cited by 1,866
Lipoprotein(a) as a cardiovascular risk factor: current status
Nordestgaard, B. G., Chapman, M. J., Ray, K., Borén, J., Andreotti, F., Watts, G. F., Ginsberg, H., Amarenco, P., Catapano, A., Descamps, O. S., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq386 · Cited by 1,807
(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Clarke, R., Peden, J. F., Hopewell, J. C., Kyriakou, T., Goel, A., Heath, S. C., Parish, S., Barlera, S., Franzosi, M. G., Rust, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902604 · Cited by 1,671
Cardiovascular disease in Europe: epidemiological update 2016
Townsend, N., Wilson, L., Bhatnagar, P., Wickramasinghe, K., Rayner, M., & Nichols, M. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw334 · Cited by 1,579
A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM
Berg, K. (1963) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1963.tb01808.x · Cited by 1,372
Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
Kamstrup, P. R. (2009) · JAMA · doi:10.1001/jama.2009.801 · Cited by 1,357
Self-citationMendelian randomization: prospects, potentials, and limitations
Smith, G. D. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh132 · Cited by 1,222
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
Tsimikas, S., Karwatowska-Prokopczuk, E., Gouni-Berthold, I., Tardif, J.-C., Baum, S. J., Steinhagen-Thiessen, E., Shapiro, M. D., Stroes, E. S., Moriarty, P. M., Nordestgaard, B. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1905239 · Cited by 1,094
Genetic Associations with Valvular Calcification and Aortic Stenosis
Thanassoulis, G., Campbell, C. Y., Owens, D. S., Smith, J. G., Smith, A. V., Peloso, G. M., Kerr, K. F., Pechlivanis, S., Budoff, M. J., Harris, T. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109034 · Cited by 1,008
Self-citationLipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk: Insights From the FOURIER Trial
O’Donoghue, M. L., Fazio, S., Giugliano, R. P., Stroes, E. S. G., Kanevsky, E., Gouni-Berthold, I., Im, K., Lira Pineda, A., Wasserman, S. M., Češka, R., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.037184 · Cited by 984
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000624 · Cited by 907
Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease
Tsimikas, S., Brilakis, E. S., Miller, E. R., McConnell, J. P., Lennon, R. J., Kornman, K. S., Witztum, J. L., & Berger, P. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043175 · Cited by 784
Dweck, M. R., Boon, N. A., & Newby, D. E. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.093 · Cited by 692
Burgess, S., Ference, B. A., Staley, J. R., Freitag, D. F., Mason, A. M., Nielsen, S. F., Willeit, P., Young, R., Surendran, P., Karthikeyan, S., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.1470 · Cited by 689
Self-citationAortic-Valve Stenosis — From Patients at Risk to Severe Valve Obstruction
Otto, C. M., & Prendergast, B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1313875 · Cited by 631
Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
Kamstrup, P. R., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.038 · Cited by 595
Self-citationNordestgaard, B. G., & Langsted, A. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r071233 · Cited by 575
Kamstrup, P. R., Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2008) · Circulation · doi:10.1161/circulationaha.107.715698 · Cited by 558
Self-citationLipid-Related Markers and Cardiovascular Disease Prediction
(2012) · JAMA · doi:10.1001/jama.2012.6571 · Cited by 539
Alfthan, G., Pekkanen, J., Jauhiainen, M., Pitkäniemi, J., Karvonen, M., Tuomilehto, J., Salonen, J. T., & Ehnholm, C. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90078-7 · Cited by 527
Wilson, D. P., Jacobson, T. A., Jones, P. H., Koschinsky, M. L., McNeal, C. J., Nordestgaard, B. G., & Orringer, C. E. (2019) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2019.04.010 · Cited by 518
Statin therapy increases lipoprotein(a) levels
Tsimikas, S., Gordts, P. L. S. M., Nora, C., Yeang, C., & Witztum, J. L. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz310 · Cited by 512
A Prospective Study of Lipoprotein(a) and the Risk of Myocardial Infarction
Ridker, P. M. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510180065035 · Cited by 512
Wellcome Trust Case Control Consortium, Trégouët, D.-A., Cardiogenics Consortium, König, I. R., Erdmann, J., Munteanu, A., Braund, P. S., Hall, A. S., Großhennig, A., Linsel-Nitschke, P., et al. (2009) · Nature Genetics · doi:10.1038/ng.314 · Cited by 475
Khera, A. V., Everett, B. M., Caulfield, M. P., Hantash, F. M., Wohlgemuth, J., Ridker, P. M., & Mora, S. (2014) · Circulation · doi:10.1161/circulationaha.113.004406 · Cited by 461
Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis
Capoulade, R., Chan, K. L., Yeang, C., Mathieu, P., Bossé, Y., Dumesnil, J. G., Tam, J. W., Teo, K. K., Mahmut, A., Yang, X., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.020 · Cited by 417
Zheng, K. H., Tsimikas, S., Pawade, T., Kroon, J., Jenkins, W. S. A., Doris, M. K., White, A. C., Timmers, N. K. L. M., Hjortnaes, J., Rogers, M. A., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.070 · Cited by 343
Lipoprotein (a) measurements for clinical application
Marcovina, S. M., & Albers, J. J. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r061648 · Cited by 338
Virani, S. S., Brautbar, A., Davis, B. C., Nambi, V., Hoogeveen, R. C., Sharrett, A. R., Coresh, J., Mosley, T. H., Morrisett, J. D., Catellier, D. J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.045120 · Cited by 324
Arsenault, B. J., Boekholdt, S. M., Dubé, M.-P., Rhéaume, É., Wareham, N. J., Khaw, K.-T., Sandhu, M. S., & Tardif, J.-C. (2014) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.113.000400 · Cited by 315
Marcovina, S. M., Albers, J. J., Scanu, A. M., Kennedy, H., Giaculli, F., Berg, K., Couderc, R., Dati, F., Rifai, N., Sakurabayashi, I., et al. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.12.1956 · Cited by 313
Kronenberg, F., Kronenberg, M. F., Kiechl, S., Trenkwalder, E., Santer, P., Oberhollenzer, F., Egger, G., Utermann, G., & Willeit, J. (1999) · Circulation · doi:10.1161/01.cir.100.11.1154 · Cited by 293
High lipoprotein(a) and high risk of mortality
Langsted, A., Kamstrup, P. R., & Nordestgaard, B. G. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy902 · Cited by 288
Self-citationDiscrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a)
Willeit, P., Kiechl, S., Kronenberg, F., Witztum, J. L., Santer, P., Mayr, M., Xu, Q., Mayr, A., Willeit, J., & Tsimikas, S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.061 · Cited by 286
Extreme lipoprotein(a) levels and improved cardiovascular risk prediction
Kamstrup, P. R., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.12.023 · Cited by 284
Self-citationMadsen, C. M., Kamstrup, P. R., Langsted, A., Varbo, A., & Nordestgaard, B. G. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.312951 · Cited by 280
Self-citationElevated Lipoprotein(a) and Risk of Ischemic Stroke
Langsted, A., Nordestgaard, B. G., & Kamstrup, P. R. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.524 · Cited by 269
Self-citationPhenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels
Emdin, C. A., Khera, A. V., Natarajan, P., Klarin, D., Won, H.-H., Peloso, G. M., Stitziel, N. O., Nomura, A., Zekavat, S. M., Bick, A. G., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.033 · Cited by 244
Lipoprotein(a) and Risk of Type 2 Diabetes
Mora, S., Kamstrup, P. R., Rifai, N., Nordestgaard, B. G., Buring, J. E., & Ridker, P. M. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.146779 · Cited by 242
Self-citationTeaching old dogmas new tricks
Brown, M. S., & Goldstein, J. L. (1987) · Nature · doi:10.1038/330113a0 · Cited by 238
Chasman, D. I., Shiffman, D., Zee, R. Y. L., Louie, J. Z., Luke, M. M., Rowland, C. M., Catanese, J. J., Buring, J. E., Devlin, J. J., & Ridker, P. M. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.019 · Cited by 228
Roeseler, E., Julius, U., Heigl, F., Spitthoever, R., Heutling, D., Breitenberger, P., Leebmann, J., Lehmacher, W., Kamstrup, P. R., Nordestgaard, B. G., et al. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.307983 · Cited by 227
Self-citationNitsch, D., Molokhia, M., Smeeth, L., DeStavola, B. L., Whittaker, J. C., & Leon, D. A. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj062 · Cited by 227
Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes
Gudbjartsson, D. F., Thorgeirsson, G., Sulem, P., Helgadottir, A., Gylfason, A., Saemundsdottir, J., Bjornsson, E., Norddahl, G. L., Jonasdottir, A., Jonasdottir, A., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.10.019 · Cited by 226
Lamina, C., Kronenberg, F., & for the Lp(a)-GWAS-Consortium (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1041 · Cited by 218
Kamstrup, P. R., & Nordestgaard, B. G. (2016) · JACC: Heart Failure · doi:10.1016/j.jchf.2015.08.006 · Cited by 206
Self-citationKamstrup, P. R., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.248765 · Cited by 194
Self-citationHelgadottir, A., Gretarsdottir, S., Thorleifsson, G., Holm, H., Patel, R. S., Gudnason, T., Jones, G. T., van Rij, A. M., Eapen, D. J., Baas, A. F., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.078 · Cited by 187
Paultre, F., Pearson, T. A., Weil, H. F. C., Tuck, C. H., Myerson, M., Rubin, J., Francis, C. K., Marx, H. F., Philbin, E. F., Reed, R. G., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.12.2619 · Cited by 174
Boffa, M. B., Marcovina, S. M., & Koschinsky, M. L. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2003.12.007 · Cited by 172
Association of Gene Variants With Incident Myocardial Infarction in the Cardiovascular Health Study
Shiffman, D., O’Meara, E. S., Bare, L. A., Rowland, C. M., Louie, J. Z., Arellano, A. R., Lumley, T., Rice, K., Iakoubova, O., Luke, M. M., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.153981 · Cited by 167
Luke, M. M., Kane, J. P., Liu, D. M., Rowland, C. M., Shiffman, D., Cassano, J., Catanese, J. J., Pullinger, C. R., Leong, D. U., Arellano, A. R., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.141291 · Cited by 160
Kamstrup, P. R., & Nordestgaard, B. G. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70064-0 · Cited by 153
Self-citationSantos, R. D., Duell, P. B., East, C. A., Guyton, J. R., Moriarty, P. M., Chin, W., & Mittleman, R. S. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht549 · Cited by 151
Koschinsky, M. L., & Marcovina, S. M. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200404000-00009 · Cited by 150
Laschkolnig, A., Kollerits, B., Lamina, C., Meisinger, C., Rantner, B., Stadler, M., Peters, A., Köenig, W., Stockl, A., Dahnhardt, D., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu107 · Cited by 146
Stiekema, L. C. A., Stroes, E. S. G., Verweij, S. L., Kassahun, H., Chen, L., Wasserman, S. M., Sabatine, M. S., Mani, V., & Fayad, Z. A. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy862 · Cited by 142
Nielsen, L. B. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00064-7 · Cited by 132
Rifai, N., Ma, J., Sacks, F. M., Ridker, P. M., Hernandez, W. J. L., Stampfer, M. J., & Marcovina, S. M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.030031 · Cited by 127
Akaike, M., Azuma, H., Kagawa, A., Matsumoto, K., Hayashi, I., Tamura, K., Nishiuchi, T., Iuchi, T., Takamori, N., Aihara, K., et al. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.9.1454 · Cited by 125
Lipoprotein(a) and ischemic heart disease—A causal association? A review
Kamstrup, P. R. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.036 · Cited by 112
Self-citationConvergent evolution of apolipoprotein(a) in primates and hedgehog
Lawn, R. M., Schwartz, K., & Patthy, L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.11992 · Cited by 104
Lipoprotein(a) and Cardiovascular Risk Prediction Among Women
Cook, N. R., Mora, S., & Ridker, P. M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.060 · Cited by 104
Mechanisms of Lipoprotein(a) Pathogenicity
Spence, J. D., & Koschinsky, M. L. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.251306 · Cited by 100
Lipoprotein(a): New insights into mechanisms of atherogenesis and thrombosis
Deb, A., & Caplice, N. M. (2004) · Clinical Cardiology · doi:10.1002/clc.4960270503 · Cited by 99
Gessi, V., Marcucci, R., Gianni, M., Grandi, A. M., Franchini, M., & Dentali, F. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0036-1598002 · Cited by 94
Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study
Parish, S., Hopewell, J. C., Hill, M. R., Marcovina, S., Valdes-Marquez, E., Haynes, R., Offer, A., Pedersen, T. R., Baigent, C., Collins, R., et al. (2018) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.117.001696 · Cited by 93
Kamstrup, P. R., Hung, M., Witztum, J. L., Tsimikas, S., & Nordestgaard, B. G. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308761 · Cited by 85
Self-citationThe effect of statins on valve function and calcification in aortic stenosis: a meta-analysis
Zhao, Y., Nicoll, R., He, Y. H., & Henein, M. Y. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.01.023 · Cited by 80
Cairns, B. J., Coffey, S., Travis, R. C., Prendergast, B., Green, J., Engert, J. C., Lathrop, M. G., Thanassoulis, G., & Clarke, R. (2017) · Circulation · doi:10.1161/circulationaha.116.026103 · Cited by 74
Tate, J. R., Rifai, N., Berg, K., Couderc, R., Dati, F., Kostner, G. M., Sakurabayashi, I., & Steinmetz, A. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.8.1629 · Cited by 72
Genetic Variants in the Apolipoprotein(a) Gene and Coronary Heart Disease
Li, Y., Luke, M. M., Shiffman, D., & Devlin, J. J. (2011) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.959601 · Cited by 70
Specific Accumulation of Lipoprotein(a) in Balloon-Injured Rabbit Aorta In Vivo
Nielsen, L. B., Stender, S., Kjeldsen, K., & Nordestgaard, B. G. (1996) · Circulation Research · doi:10.1161/01.res.78.4.615 · Cited by 70
Hopewell, J. C., Clarke, R., Parish, S., Armitage, J., Lathrop, M. G., Hager, J., & Collins, R. (2011) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.110.958371 · Cited by 61
Kyriakou, T., Seedorf, U., Goel, A., Hopewell, J. C., Clarke, R., Watkins, H. C., & Farrall, M. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303462 · Cited by 61
Arsenault, B. J., Pelletier, W., Kaiser, Y., Perrot, N., Couture, C., Khaw, K., Wareham, N. J., Bossé, Y., Pîbarot, P., Stroes, E. S. G., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.0129 · Cited by 61
Immunolocalization of Lipoprotein(a) in Wounded Tissues
Yano, Y., Shimokawa, K., Okada, Y., & Noma, A. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704500408 · Cited by 58
Ronald, J., Rajagopalan, R., Cerrato, F. E., Nord, A. S., Hatsukami, T. S., Kohler, T. R., Marcovina, S. M., Heagerty, P. J., & Jarvik, G. P. (2010) · Stroke · doi:10.1161/strokeaha.110.591230 · Cited by 52
Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population
Lim, E. T., Würtz, P., Havulinna, A. S., Palta, P., Tukiainen, T., Rehnström, K., Esko, T., Mägi, R., Inouye, M., Lappalainen, T., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004494 · Cited by 49
Danik, J. S., Buring, J. E., Chasman, D. I., Zee, R. Y. L., Ridker, P. M., & Glynn, R. J. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12056 · Cited by 46
Shiffman, D., Kane, J. P., Louie, J. Z., Arellano, A. R., Ross, D. A., Catanese, J. J., Malloy, M. J., Ellis, S. G., & Devlin, J. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002895 · Cited by 39
Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism
Sticchi, E., Magi, A., Kamstrup, P. R., Marcucci, R., Prisco, D., Martinelli, I., Mannucci, P. M., Abbate, R., & Giusti, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149427 · Cited by 36
Self-citationTsimikas, S. (2018) · Journal of Lipid Research · doi:10.1194/jlr.c085639 · Cited by 25
Cited by
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Kronenberg, F., Mora, S., Stroes, E. S. G., Ference, B. A., Arsenault, B. J., Berglund, L., Dweck, M. R., Koschinsky, M., Lambert, G., Mach, F., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac361 · Cited by 1,449
Reyes-Soffer, G., Ginsberg, H. N., Berglund, L., Duell, P. B., Heffron, S. P., Kamstrup, P. R., Lloyd-Jones, D. M., Marcovina, S. M., Yeang, C., Koschinsky, M. L., et al. (2022) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atv.0000000000000147 · Cited by 836
Self-citationDuan, Y., Gong, K., Xu, S., Zhang, F., Meng, X., & Han, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01125-5 · Cited by 538
A Modern Approach to Dyslipidemia
Berberich, A. J., & Hegele, R. A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab037 · Cited by 469
Metadata
- Authors
- Kamstrup, P. R.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-11-25
- Volume
- 67
- Issue
- 1
- Pages
- 154-166
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W3108845718
- Cited by
- 256
- References
- 87
- FWCI
- 23.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.